13F-HR: CVS Health Discloses Q2 2025 Equity Holdings in Latest 13F Filing

CVS Health Corp. has filed its Q2 2025 13F report, revealing equity holdings totaling over $190 million, primarily in the SPDR S&P 500 ETF Trust.

Summary

• CVS Health Corp. reported its equity holdings for the quarter ended June 30, 2025, totaling $190,640,383 across three distinct positions.
• Key investments include 307,891 shares of SPDR S&P 500 ETF Trust, valued at $190,230,454.
• Other holdings include 32,273 shares of Health Catalyst Inc., valued at $121,667.
• The portfolio also contains 2,683 shares of Prudential Financial Inc., valued at $288,262.
• The report was signed by Michael Motolo, Executive Director, on August 1, 2025.

Sentiment

Score: 5

Explanation: A 13F filing is a factual disclosure of historical holdings and does not inherently convey positive or negative sentiment about the company's operational performance, but rather its investment strategy. The sentiment is neutral as it simply reports historical data.

Positives

• The portfolio includes a significant position in a broad market ETF (SPDR S&P 500 ETF Trust), indicating a strategy for diversified market exposure.

Negatives

• The reported portfolio consists of only three distinct equity holdings, which may suggest a concentrated investment approach or that this disclosure represents only a segment of total investment activities.

Risks

• Investment performance is inherently subject to market fluctuations, particularly impacting the substantial holding in the SPDR S&P 500 ETF Trust.
• A limited number of distinct equity positions introduces concentration risk.

Future Outlook

This filing is a historical snapshot of equity holdings and does not provide forward-looking statements or guidance regarding CVS Health Corp.'s future operational performance or investment strategy.

Management Comments

• Michael Motolo, Executive Director, signed the report, affirming its accuracy and completeness on behalf of CVS Health Corp.

Industry Context

This 13F filing provides a snapshot of CVS Health Corp.'s public equity investment portfolio, a standard disclosure for institutional investment managers, reflecting their positions in the broader market and specific companies.

Comparison to Industry Standards

• The filing adheres to the standard SEC Form 13F disclosure requirements for institutional investment managers, providing transparency into their equity holdings.
• The portfolio's concentration in a broad market ETF (SPDR S&P 500 ETF Trust) is a common strategy among institutional investors seeking diversified market exposure.

Stakeholder Impact

• Shareholders gain transparency into the company's public equity investment portfolio, which can inform their understanding of asset management strategies.
• Investors receive insights into the institutional investment activities and market positions of a major healthcare entity.

Next Steps

• NA

Key Dates

Keywords

CVS Health, 13F filing, institutional holdings, equity investments, portfolio disclosure, SPDR S&P 500 ETF, Prudential Financial, Health Catalyst